BioCryst Pharmaceuticals, Inc. BCRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

80/100

5/7 Pass

SharesGrow Intrinsic Value

BioCryst Pharmaceuticals, Inc. (BCRX) has 20 known insider and institutional holders on record. The largest holder is BAKER BROS. ADVISORS LP with 1,607,944 shares. Other notable holders include Stonehouse Jon P and Gayer Charles K.

Over the last 12 months, insiders have made 56 transactions in BCRX stock — 28 buys (valued at $3.62M) and 5 sells (valued at $915.82K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

BCRX Insider Ownership

Top Holder

BAKER BROS. ADVISORS LP

1,607,944 shares

Buys (12 mo)

$3.62M value

Sells (12 mo)

$915.82K value

12-Month Transaction Activity

Buy 50%

Sell 9%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Baker Bros. Advisors Lp	10 Percent Owner	1,607,944	2016-08-16	100%
2	Stonehouse Jon P	Director	1,323,850	2026-03-03	82%
3	Gayer Charles K	President and Cco	878,350	2025-12-23	55%
4	Barnes Alane P	Chief Legal Officer	420,524	2025-12-23	26%
5	Thackray Helen M.	Chief R&d Officer	377,318	2025-04-02	23%
6	Ghias Babar	Chief Financial Officer	268,700	2025-12-19	17%
7	Dullinger Ronald	Chief Commercial Officer	258,372	2026-01-09	16%
8	Doyle Anthony	Chief Financial Officer	250,100	2024-12-23	16%
9	Babu Yarlagadda S	Chief Discovery Officer	230,056	2022-03-09	14%
10	Sniecinski Megan	Chief Business Officer	225,000	2020-12-17	14%
11	Powell Lynne	Senior VP - Cco	190,000	2018-12-21	12%
12	Ingram Robert Alexander	Director	100,198	2023-03-02	6%
13	Milano Vincent	Director	92,067	2026-03-03	6%
14	Sheridan William P	Chief Medical Officer	50,791	2021-12-16	3%
15	Aselage Steve	Director	49,933	2024-06-14	3%
16	Mckee Amy E	Director	42,432	2026-03-03	3%
17	Lee Kenneth B Jr	Director	39,072	2023-06-15	2%
18	Abercrombie George B	Director	36,431	2024-06-14	2%
19	Sanders Machelle	Director	30,642	2025-11-17	2%
20	Erck Stanley C	Director	30,000	2018-06-22	2%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-20	Heggie Theresa	Director	Option Exercise (Sell)	49,933	$6.30	$314.58K
2026-03-16	Barnes Alane P	Chief Legal Officer	Option Exercise (Sell)	150,000	$5.51	$826.5K
2026-02-27	Mckee Amy E	Director	RSU Award	642	$8.75	$5.62K
2026-02-27	Milne Jill C.	Director	RSU Award	528	$8.75	$4.62K
2026-02-27	Frank Steven	Director	RSU Award	1,285	$8.75	$11.24K
2026-03-02	Stonehouse Jon P	Director	Option Exercise (Sell)	305,995	$3.22	$985.3K
2026-02-27	Stonehouse Jon P	Director	RSU Award	421	$8.75	$3.68K
2026-02-27	Milano Vincent	Director	RSU Award	848	$8.75	$7.42K
2026-01-23	Milne Jill C.	Director	RSU Award	2,582	$8.55	$22.08K
2026-01-23	Milne Jill C.	Director	Unknown	-	-	-
2026-12-17	Dullinger Ronald	Chief Commercial Officer	Unknown	255,050	$7.13	$1.82M
2026-01-01	Dullinger Ronald	Chief Commercial Officer	Unknown	-	-	-
2025-12-19	Dullinger Ronald	Chief Commercial Officer	Unknown	68,500	$7.39	$506.22K
2024-12-14	Dullinger Ronald	Chief Commercial Officer	Unknown	57,100	$6.43	$367.15K
2023-12-19	Dullinger Ronald	Chief Commercial Officer	Unknown	57,100	$10.63	$606.97K
2022-12-14	Dullinger Ronald	Chief Commercial Officer	Unknown	41,000	$11.43	$468.63K
2021-12-15	Dullinger Ronald	Chief Commercial Officer	Unknown	100,000	$8.31	$831K
2020-11-29	Dullinger Ronald	Chief Commercial Officer	Unknown	100,000	$2.85	$285K
2025-12-22	Gayer Charles K	President and Cco	Option Exercise (Sell)	50,000	$5.51	$275.5K
2025-12-19	Gayer Charles K	President and Cco	Tax Withholding of RSU	11,477	$7.41	$85.04K
2025-12-22	Barnes Alane P	Chief Legal Officer	Informative Sell	21,773	$7.65	$166.56K
2025-12-19	Barnes Alane P	Chief Legal Officer	Tax Withholding of RSU	16,902	$7.41	$125.24K
2025-12-19	Stonehouse Jon P	Chief Executive Officer	Tax Withholding of RSU	61,793	$7.41	$457.89K
2025-12-17	Ghias Babar	Chief Financial Officer	RSU Award	121,700	-	-
2025-12-17	Gayer Charles K	President and Cco	RSU Award	471,000	-	-